Shares of Oklo Inc. slid -4.2% to $58.00 on March 18 after the advanced nuclear startup reported a fourth-quarter loss far worse than Wall Street expected — and pushed back the timeline for its first reactor, forcing investors to reckon with how much more cash they'll need to burn before a single watt hits the grid.

Oklo Posts a $139M Loss and Pushes Its First Reactor to 2028 — Can a $9.5 Billion Valuation Survive on Promises Alone?

Shares slid -4.2% to $58.00 after Oklo, the advanced nuclear startup backed by big-name AI partnerships, delivered a Q4 earnings miss that laid bare the brutal economics of building a reactor from scratch with zero revenue. The results landed during a broader market downturn, but Oklo's problems are distinctly its own.

• The Loss Was Nearly Twice What Wall Street Expected

Oklo reported Q4 EPS of -$0.27, missing the consensus estimate of -$0.17 by nearly 59%.

Full-year operating expenses surged to $139.3 million, up from $52.8 million in 2024 — a 164% jump driven largely by payroll and construction ramp-up. The company hasn't booked any revenue from power or radioisotope sales, and no reactor has been built yet. Investors are paying a $9.5 billion market cap for a firm that is, by every traditional measure, pre-revenue.

• The Cash Pile Is Big, but So Is the Burn Rate Ahead

By year-end 2025, Oklo held $788.4 million in cash plus $624.1 million in marketable securities.

It then raised another $1.18 billion in early 2026. That sounds like a fortress — until you see the guidance: management expects to burn $80–100 million on operations and spend $350–450 million on investments in 2026 alone. At the midpoint, roughly $475 million goes out the door this year, meaning the current war chest may last only about five years if costs don't escalate — a big "if" for first-of-a-kind nuclear construction.

• The Idaho Reactor Slipped, and Delays in Nuclear Tend to Compound

Oklo's first commercial reactor at Idaho National Laboratory is now targeting heat production in 2028, a shift from prior expectations that management attributed to "realities of first-of-a-kind construction." History is unkind to nuclear timelines. Every year of delay means more cash burned before any revenue offsets it, eroding the return on Oklo's invested capital.

• Analysts Are Cutting Targets While Insiders Head for the Exit

Craig-Hallum slashed its price target to $71 from $87.

Needham cut to $73 from $135.

Canaccord dropped to $125 from $175. Most kept positive ratings — but insiders have sold roughly $170 million in stock over the past 90 days , including sales by the CEO and CFO at $60 per share days before the earnings report. That gap between analyst optimism and insider behavior is hard to ignore.